<script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app22.us.archive.org';v.server_ms=430;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include --><!-- BEGIN WAYBACK TOOLBAR INSERT -->
<script type="text/javascript" src="/static/js/timestamp.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/graph-calc.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/auto-complete.js?v=1531166943.0" charset="utf-8"></script>
<script type="text/javascript" src="/static/js/toolbar.js?v=1531166943.0" charset="utf-8"></script>

<style type="text/css">
body {
  margin-top:0 !important;
  padding-top:0 !important;
  /*min-width:800px !important;*/
}
.wb-autocomplete-suggestions {
    text-align: left; cursor: default; border: 1px solid #ccc; border-top: 0; background: #fff; box-shadow: -1px 1px 3px rgba(0,0,0,.1);
    position: absolute; display: none; z-index: 2147483647; max-height: 254px; overflow: hidden; overflow-y: auto; box-sizing: border-box;
}
.wb-autocomplete-suggestion { position: relative; padding: 0 .6em; line-height: 23px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; font-size: 1.02em; color: #333; }
.wb-autocomplete-suggestion b { font-weight: bold; }
.wb-autocomplete-suggestion.selected { background: #f0f0f0; }
</style>
<div id="wm-ipp" lang="en" style="display:none;direction:ltr;">
<div style="position:fixed;left:0;top:0;right:0;">
<div id="wm-ipp-inside">
  <div style="position:relative;">
    <div id="wm-logo" style="float:left;width:130px;padding-top:10px;">
      <a href="/web/" title="Wayback Machine home page"><img src="/static/images/toolbar/wayback-toolbar-logo.png" alt="Wayback Machine" width="110" height="39" border="0" /></a>
    </div>
    <div class="r" style="float:right;">
      <div id="wm-btns" style="text-align:right;height:25px;">
                  <div id="wm-save-snapshot-success">success</div>
          <div id="wm-save-snapshot-fail">fail</div>
          <a href="#"
             onclick="__wm.saveSnapshot('https://www.guideline.gov/summaries/downloadcontent/ngc-9772?contentType=xml', '20180716010727')"
             title="Share via My Web Archive"
             id="wm-save-snapshot-open"
          >
            <span class="iconochive-web"></span>
          </a>
          <a href="https://archive.org/account/login.php"
             title="Sign In"
             id="wm-sign-in"
          >
            <span class="iconochive-person"></span>
          </a>
          <span id="wm-save-snapshot-in-progress" class="iconochive-web"></span>
        	<a href="http://faq.web.archive.org/" title="Get some help using the Wayback Machine" style="top:-6px;"><span class="iconochive-question" style="color:rgb(87,186,244);font-size:160%;"></span></a>
	<a id="wm-tb-close" href="#close" onclick="__wm.h(event);return false;" style="top:-2px;" title="Close the toolbar"><span class="iconochive-remove-circle" style="color:#888888;font-size:240%;"></span></a>
      </div>
      <div id="wm-share" style="text-align:right;">
	<a href="#" onclick="window.open('https://www.facebook.com/sharer/sharer.php?u=https://web.archive.org/web/20180716010727/https://www.guideline.gov/summaries/downloadcontent/ngc-9772?contentType=xml', '', 'height=400,width=600'); return false;" title="Share on Facebook" style="margin-right:5px;" target="_blank"><span class="iconochive-facebook" style="color:#3b5998;font-size:160%;"></span></a>
	<a href="#" onclick="window.open('https://twitter.com/intent/tweet?text=https://web.archive.org/web/20180716010727/https://www.guideline.gov/summaries/downloadcontent/ngc-9772?contentType=xml&amp;via=internetarchive', '', 'height=400,width=600'); return false;" title="Share on Twitter" style="margin-right:5px;" target="_blank"><span class="iconochive-twitter" style="color:#1dcaff;font-size:160%;"></span></a>
      </div>
    </div>
    <table class="c" style="">
      <tbody>
	<tr>
	  <td class="u" colspan="2">
	    <form target="_top" method="get" action="/web/submit" name="wmtb" id="wmtb"><input type="text" name="url" id="wmtbURL" value="https://www.guideline.gov/summaries/downloadcontent/ngc-9772?contentType=xml" onfocus="this.focus();this.select();" /><input type="hidden" name="type" value="replay" /><input type="hidden" name="date" value="20180716010727" /><input type="submit" value="Go" /></form>
	  </td>
	  <td class="n" rowspan="2" style="width:110px;">
	    <table>
	      <tbody>
		<!-- NEXT/PREV MONTH NAV AND MONTH INDICATOR -->
		<tr class="m">
		  <td class="b" nowrap="nowrap"><a href="https://web.archive.org/web/20180610075600/https://www.guideline.gov/summaries/downloadcontent/ngc-9772?contentType=xml" title="10 Jun 2018"><strong>Jun</strong></a></td>
		  <td class="c" id="displayMonthEl" title="You are here: 01:07:27 Jul 16, 2018">JUL</td>
		  <td class="f" nowrap="nowrap">Aug</td>
		</tr>
		<!-- NEXT/PREV CAPTURE NAV AND DAY OF MONTH INDICATOR -->
		<tr class="d">
		  <td class="b" nowrap="nowrap"><a href="https://web.archive.org/web/20180712211731/https://www.guideline.gov/summaries/downloadcontent/ngc-9772?contentType=xml" title="21:17:31 Jul 12, 2018"><img src="/static/images/toolbar/wm_tb_prv_on.png" alt="Previous capture" width="14" height="16" border="0" /></a></td>
		  <td class="c" id="displayDayEl" style="width:34px;font-size:24px;white-space:nowrap;" title="You are here: 01:07:27 Jul 16, 2018">16</td>
		  <td class="f" nowrap="nowrap"><img src="/static/images/toolbar/wm_tb_nxt_off.png" alt="Next capture" width="14" height="16" border="0" /></td>
		</tr>
		<!-- NEXT/PREV YEAR NAV AND YEAR INDICATOR -->
		<tr class="y">
		  <td class="b" nowrap="nowrap"><a href="https://web.archive.org/web/20160930170615/https://www.guideline.gov/summaries/downloadcontent/ngc-9772?contentType=xml" title="30 Sep 2016"><strong>2016</strong></a></td>
		  <td class="c" id="displayYearEl" title="You are here: 01:07:27 Jul 16, 2018">2018</td>
		  <td class="f" nowrap="nowrap">2019</td>
		</tr>
	      </tbody>
	    </table>
	  </td>
	</tr>
	<tr>
	  <td class="s">
	    	    <div id="wm-nav-captures">
	      	      <a class="t" href="/web/20180716010727*/https://www.guideline.gov/summaries/downloadcontent/ngc-9772?contentType=xml" title="See a list of every capture for this URL">7 captures</a>
	      <div class="r" title="Timespan for captures of this URL">30 Sep 2016 - 16 Jul 2018</div>
	      </div>
	  </td>
	  <td class="k">
	    <a href="" id="wm-graph-anchor">
	      <div id="wm-ipp-sparkline" title="Explore captures for this URL" style="position: relative">
		<canvas id="wm-sparkline-canvas" width="575" height="27" border="0"></canvas>
	      </div>
	    </a>
	  </td>
	</tr>
      </tbody>
    </table>
    <div style="position:absolute;bottom:0;right:2px;text-align:right;">
      <a id="wm-expand" class="wm-btn wm-closed" href="#expand" onclick="__wm.ex(event);return false;"><span id="wm-expand-icon" class="iconochive-down-solid"></span> <span style="font-size:80%">About this capture</span></a>
    </div>
  </div>
    <div id="wm-capinfo" style="border-top:1px solid #777;display:none; overflow: hidden">
            <div style="background-color:#666;color:#fff;font-weight:bold;text-align:center">COLLECTED BY</div>
    <div style="padding:3px;position:relative" id="wm-collected-by-content">
      <div style="display:inline-block;vertical-align:top;width:49%;">
			<span class="c-logo" style="background-image:url(https://archive.org/services/img/liveweb)"></span>
		<div>Collection: <a style="color:#33f;" href="https://archive.org/details/liveweb" target="_new"><span class="wm-title">Live Web Proxy Crawls</span></a></div>
		<div style="max-height:75px;overflow:hidden;position:relative;">
	  <div style="position:absolute;top:0;left:0;width:100%;height:75px;background:linear-gradient(to bottom,rgba(255,255,255,0) 0%,rgba(255,255,255,0) 90%,rgba(255,255,255,255) 100%);"></div>
	  Content crawled via the <a href="http://archive.org/web/web.php">Wayback Machine</a> Live Proxy mostly by the Save Page Now feature on web.archive.org.
<br /><br />
Liveweb proxy is a component of Internet Archive’s wayback machine project. The liveweb proxy captures the content of a web page in real time, archives it into a ARC or WARC file and returns the ARC/WARC record back to the wayback machine to process. The recorded ARC/WARC file becomes part of the wayback machine in due course of time.
<br /><br />
	</div>
	      </div>
    </div>
    <div style="background-color:#666;color:#fff;font-weight:bold;text-align:center" title="Timestamps for the elements of this page">TIMESTAMPS</div>
    <div>
      <div id="wm-capresources" style="margin:0 5px 5px 5px;max-height:250px;overflow-y:scroll !important"></div>
      <div id="wm-capresources-loading" style="text-align:left;margin:0 20px 5px 5px;display:none"><img src="/static/images/loading.gif" alt="loading" /></div>
    </div>
  </div></div></div></div><script type="text/javascript">
__wm.bt(575,27,25,2,"web","https://www.guideline.gov/summaries/downloadcontent/ngc-9772?contentType=xml","2018-07-16",1996);
</script>
<!-- END WAYBACK TOOLBAR INSERT --><version>
  <xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource>
  <section secid="390" ordby="100" name="General">
    <field fieldid="161" ordby="105" id="391" name="Guideline Title" type="text">
      <fieldvalue value="<div class=&quot;content_title&quot;>Nutritional support after spinal cord injury. In: Guidelines for the management of acute cervical spine and spinal cord injuries.</div>"/>
    </field>
    <field fieldid="97" ordby="110" id="392" name="Bibliographic Source(s)" type="citation">
      <fieldvalue value="<table><tr><td>Dhall SS, Hadley MN, Aarabi B, Gelb DE, Hurlbert RJ, Rozzelle CJ, Ryken TC, Theodore N, Walters BC. Nutritional support after spinal cord injury. In: Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery. 2013 Mar;72(Suppl 2):255-9. [27 references] <a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=23417196&quot; target=&quot;_blank&quot;>PubMed</a></td></tr></table>"/>
    </field>
    <field fieldid="120" ordby="115" id="393" name="Guideline Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This is the current release of the guideline.</p></div>"/>
    </field>
  </section>
  <section secid="420" ordby="300" name="Recommendations">
    <field fieldid="151" ordby="310" id="421" name="Major Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The rating schemes used for the strength of the evidence (<strong>Class I-III</strong>) and the levels of recommendations (<strong>Level I-III</strong>) are defined at the end of the &quot;Major Recommendations&quot; field.</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Recommendations</span></strong></p>
<p><strong>Level II</strong></p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>Indirect calorimetry as the best means to determine the caloric needs of spinal cord injury (SCI) patients is recommended. </li>
</ul>
<p><strong>Level III</strong></p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>Nutritional support of SCI patients is recommended as soon as feasible. It appears that early enteral nutrition (initiated within 72 hours) is safe, but has not been shown to affect neurological outcome, the length of stay, or the incidence of complications in patients with acute SCI. </li>
</ul>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Summary</span></strong></p>
<p>Alterations in metabolism occur after acute SCI, but the marked hypermetabolic response seen after acute traumatic brain injury appears to be blunted in SCI patients by the flaccidity of denervated musculature after spinal cord transection/injury. As a result, resting energy expenditure (REE) is lower than predicted after acute SCI. Equation estimates of REE in these patients have proven to be inaccurate. Comparative <strong>Class II</strong> medical evidence supports the use of indirect calorimetry as the recommended technique to assess energy expenditure in both the acute and chronic settings among patients with SCI.</p>
<p>Protein catabolism does occur after acute, severe SCI, and marked losses in lean body mass due to muscle atrophy result in huge nitrogen losses, prolonged negative nitrogen balance, and rapid weight loss. Nutritional support of the SCI patient to meet caloric and nitrogen needs, not to achieve nitrogen balance, is safe and may reduce the deleterious effects of the catabolic, nitrogen wasting process that occurs after acute SCI. It appears that early enteral nutrition (initiated within 72 hours) is safe, but has not been shown to affect neurological outcome, the length of stay, or the incidence of complications in patients with acute SCI.</p>
<p><strong><span style=&quot;text-decoration: underline;&quot;>Definitions</span></strong>:</p>
<p><strong>Rating Scheme for the Strength of the Evidence: Modified North American Spine Society Schema to Conform to Neurosurgical Criteria as Previously Published and for Ease of Understanding and Implementation: Levels of Evidence for Primary Research Question<sup>a</sup></strong></p>
<table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Rating Scheme for the Strength of the Evidence: Modified North American Spine Society Schema to Conform to Neurosurgical Criteria as Previously Published and for Ease of Understanding and Implementation: Levels of Evidence for Primary Research Question&quot;>
    <thead>
        <tr>
            <th valign=&quot;top&quot;>Class</th>
            <th valign=&quot;top&quot;>Therapeutic Studies: Investigating the Results of Treatment</th>
            <th valign=&quot;top&quot;>Diagnostic Studies: Investigating a Diagnostic Test</th>
            <th valign=&quot;top&quot;>Clinical Assessment: Studies of Reliability and Validity of Observations, Including Clinical Examination, Imaging Results, and Classifications</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot; rowspan=&quot;2&quot;>I</td>
            <td valign=&quot;top&quot;>High-quality randomized controlled trial with statistically significant difference or no statistically significant difference but narrow confidence intervals</td>
            <td valign=&quot;top&quot;>Testing of previously developed diagnostic criteria on consecutive patients (with universally applied reference &quot;gold&quot; standard)</td>
            <td valign=&quot;top&quot;>Evidence provided by 1 or more well-designed clinical studies in which interobserver and intraobserver reliability is represented by a ĸ statistic &amp;ge;0.60 or an intraclass correlation coefficient of &amp;ge;0.70</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class I randomized controlled trials (and study results were homogeneous<sup>c</sup>)</td>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class I studies</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot; rowspan=&quot;6&quot;>II</td>
            <td valign=&quot;top&quot;>Lesser-quality randomized controlled trial (e.g., &amp;lt;80% follow-up, no blinding, or improper randomization)</td>
            <td valign=&quot;top&quot;>Development of diagnostic criteria on consecutive patients (with universally applied reference &quot;gold&quot; standard)</td>
            <td valign=&quot;top&quot;>Evidence provided by 1 or more well-designed clinical studies in which interobserver and intraobserver reliability is represented by a ĸ statistic of 0.40&amp;ndash;0.60 or an intraclass correlation coefficient of 0.50&amp;ndash;0.70</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Prospective<sup>d</sup> comparative study<sup>e</sup></td>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class II studies</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class II studies or Class I studies with inconsistent results</td>
            <td valign=&quot;top&quot;>Study of nonconsecutive patients; without consistently applied reference &quot;gold&quot; standard</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Case-control study<sup>g</sup></td>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class III studies</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Retrospective<sup>f</sup> comparative study<sup>e</sup></td>
            <td valign=&quot;top&quot;>Case-control study</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class II studies</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot; rowspan=&quot;2&quot;>III</td>
            <td valign=&quot;top&quot;>Case series<sup>h</sup></td>
            <td valign=&quot;top&quot;>Poor reference standard</td>
            <td valign=&quot;top&quot;>Evidence provided by 1 or more well-designed clinical studies in which interobserver and intraobserver reliability is represented by a ĸ statistic of &amp;lt;0.40 or an intraclass correlation coefficient of &amp;lt;0.50</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Expert opinion</td>
            <td valign=&quot;top&quot;>Expert opinion</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
    </tbody>
</table>
<p class=&quot;Note&quot;><sup>a</sup>A complete assessment of quality of individual studies requires critical appraisal of all aspects of the study design.</p>
<p class=&quot;Note&quot;><sup>b</sup>A combination of results from 2 or more prior studies.</p>
<p class=&quot;Note&quot;><sup>c</sup>Studies provided consistent results.</p>
<p class=&quot;Note&quot;><sup>d</sup>Study was started before the first patient enrolled.</p>
<p class=&quot;Note&quot;><sup>e</sup>Patients treated 1 way (e.g., halo vest orthosis) compared with a group of patients treated in another way (e.g., internal fixation) at the same institution.</p>
<p class=&quot;Note&quot;><sup>f</sup>The study was started after the first patient was enrolled.</p>
<p class=&quot;Note&quot;><sup>g</sup>Patients identified for the study on the basis of their outcome, called &quot;cases&quot; (e.g., failed fusion), are compared with those who did not have outcome, called &quot;controls&quot; (e.g., successful fusion).</p>
<p class=&quot;Note&quot;><sup>h</sup>Patients treated 1 way with no comparison group of patients treated in another way.</p>
<p><strong>Levels of Recommendation</strong></p>
<table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Levels of Recommendation&quot;>
    <tbody>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>Level I</td>
            <td valign=&quot;top&quot;>Generally accepted principles for patient management, which reflect a high degree of clinical certainty (usually this requires Class I evidence which directly addresses the clinical questions or overwhelming Class II evidence when circumstances preclude randomized clinical trials)</td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>Level II</td>
            <td valign=&quot;top&quot;>Recommendations for patient management which reflect moderate clinical certainty (usually this requires Class II evidence or a strong consensus of Class III evidence)</td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>Level III</td>
            <td valign=&quot;top&quot;>Other strategies for patient management for which the clinical utility is uncertain (inconclusive or conflicting evidence or opinion)</td>
        </tr>
    </tbody>
</table></div>"/>
    </field>
    <field fieldid="138" ordby="330" id="423" name="Clinical Algorithm(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>None provided</p></div>"/>
    </field>
  </section>
  <section secid="396" ordby="400" name="Scope">
    <field fieldid="140" ordby="405" id="397" name="Disease/Condition(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Hypermetabolism, catabolism and accelerated nitrogen losses following spinal cord injury</p></div>"/>
    </field>
    <field fieldid="103" ordby="410" id="398" name="Guideline Category" type="picklist-many">
      <fieldvalue value="Evaluation"/>
      <fieldvalue value="Management"/>
    </field>
    <field fieldid="113" ordby="415" id="399" name="Clinical Specialty" type="picklist-many">
      <fieldvalue value="Critical Care"/>
      <fieldvalue value="Neurological Surgery"/>
      <fieldvalue value="Neurology"/>
      <fieldvalue value="Nutrition"/>
      <fieldvalue value="Orthopedic Surgery"/>
    </field>
    <field fieldid="114" ordby="420" id="400" name="Intended Users" type="picklist-many">
      <fieldvalue value="Advanced Practice Nurses"/>
      <fieldvalue value="Dietitians"/>
      <fieldvalue value="Physician Assistants"/>
      <fieldvalue value="Physicians"/>
    </field>
    <field fieldid="129" ordby="425" id="401" name="Guideline Objective(s)" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>To update the medical evidence on nutritional support after spinal cord injury (SCI) since the original publication</p></div>"/>
    </field>
    <field fieldid="132" ordby="430" id="402" name="Target Population" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Patients with acute spinal cord injuries (SCIs) </p></div>"/>
    </field>
    <field fieldid="133" ordby="435" id="403" name="Interventions and Practices Considered" type="text">
      <fieldvalue value="<ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;>
    <li>Indirect calorimetry to determine caloric needs </li>
    <li>Early enteral nutrition initiated within 72 hours </li>
</ol>"/>
    </field>
    <field fieldid="134" ordby="440" id="404" name="Major Outcomes Considered" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>Incidence of infection </li>
    <li>Nutritional status </li>
    <li>Feeding complications </li>
    <li>Respiratory complications </li>
    <li>Number of ventilator hours </li>
    <li>Length of stay </li>
    <li>Resting energy expenditure </li>
    <li>Nitrogen loss </li>
    <li>Neurological outcome </li>
</ul>"/>
    </field>
  </section>
  <section secid="405" ordby="500" name="Methodology">
    <field fieldid="109" ordby="505" id="406" name="Methods Used to Collect/Select the Evidence" type="picklist-many">
      <fieldvalue value="Hand-searches of Published Literature (Primary Sources)"/>
      <fieldvalue value="Hand-searches of Published Literature (Secondary Sources)"/>
      <fieldvalue value="Searches of Electronic Databases"/>
    </field>
    <field fieldid="135" ordby="510" id="407" name="Description of Methods Used to Collect/Select the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong>Search Criteria</strong></p>
<p>A National Library of Medicine (PubMed) computerized literature search from 1966 to 2011 was undertaken using Medical Subject Headings in combination with &quot;spinal cord injury&quot;: &quot;nutrition&quot; (138 citations) and &quot;nutritional support&quot; (73 citations). Non-English language and duplicate citations were deleted. Titles and abstracts of the remaining publications were reviewed. A focused search on the specific issue of nutrition and human patients with acute spinal cord injuries (SCI) identified 16 citations. Relevant manuscripts and reviews describing nutritional support of head-injured patients and several reports describing the nutritional status of chronic SCI patients are included in the bibliography. These efforts identified 7 Class III medical evidence studies, which describe metabolism, nitrogen wasting and the effect of feeding on nitrogen balance, and serum biochemistries in patients after acute SCI. Four of the 7 citations offer Class II medical evidence on indirect calorimetry to assess energy expenditure after SCI. There were no studies that examined the effects of nutritional support on neurological outcome following acute SCI.</p></div>"/>
    </field>
    <field fieldid="136" ordby="515" id="408" name="Number of Source Documents" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Seven Class III medical evidence studies are summarized in Evidentiary Table format (see the table in the original guideline document).</p></div>"/>
    </field>
    <field fieldid="115" ordby="520" id="409" name="Methods Used to Assess the Quality and Strength of the Evidence" type="picklist-choice">
      <fieldvalue value="Weighting According to a Rating Scheme (Scheme Given)"/>
    </field>
    <field fieldid="149" ordby="525" id="410" name="Rating Scheme for the Strength of the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong>Rating Scheme for the Strength of the Evidence: Modified North American Spine Society Schema to Conform to Neurosurgical Criteria as Previously Published and for Ease of Understanding and Implementation: Levels of Evidence for Primary Research Question<sup>a</sup></strong></p>
<table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Rating Scheme for the Strength of the Evidence: Modified North American Spine Society Schema to Conform to Neurosurgical Criteria as Previously Published and for Ease of Understanding and Implementation: Levels of Evidence for Primary Research Question&quot;>
    <thead>
        <tr>
            <th valign=&quot;top&quot;>Class</th>
            <th valign=&quot;top&quot;>Therapeutic Studies: Investigating the Results of Treatment</th>
            <th valign=&quot;top&quot;>Diagnostic Studies: Investigating a Diagnostic Test</th>
            <th valign=&quot;top&quot;>Clinical Assessment: Studies of Reliability and Validity of Observations, Including Clinical Examination, Imaging Results, and Classifications</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot; rowspan=&quot;2&quot;>I</td>
            <td valign=&quot;top&quot;>High-quality randomized controlled trial with statistically significant difference or no statistically significant difference but narrow confidence intervals</td>
            <td valign=&quot;top&quot;>Testing of previously developed diagnostic criteria on consecutive patients (with universally applied reference &quot;gold&quot; standard)</td>
            <td valign=&quot;top&quot;>Evidence provided by 1 or more well-designed clinical studies in which interobserver and intraobserver reliability is represented by a ĸ statistic &amp;ge;0.60 or an intraclass correlation coefficient of &amp;ge;0.70</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class I randomized controlled trials (and study results were homogeneous<sup>c</sup>)</td>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class I studies</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot; rowspan=&quot;6&quot;>II</td>
            <td valign=&quot;top&quot;>Lesser-quality randomized controlled trial (e.g., &amp;lt;80% follow-up, no blinding, or improper randomization)</td>
            <td valign=&quot;top&quot;>Development of diagnostic criteria on consecutive patients (with universally applied reference &quot;gold&quot; standard)</td>
            <td valign=&quot;top&quot;>Evidence provided by 1 or more well-designed clinical studies in which interobserver and intraobserver reliability is represented by a ĸ statistic of 0.40&amp;ndash;0.60 or an intraclass correlation coefficient of 0.50&amp;ndash;0.70</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Prospective<sup>d</sup> comparative study<sup>e</sup></td>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class II studies</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class II studies or Class I studies with inconsistent results</td>
            <td valign=&quot;top&quot;>Study of nonconsecutive patients; without consistently applied reference &quot;gold&quot; standard</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Case-control study<sup>g</sup></td>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class III studies</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Retrospective<sup>f</sup> comparative study<sup>e</sup></td>
            <td valign=&quot;top&quot;>Case-control study</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Systematic review<sup>b</sup> of Class II studies</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot; rowspan=&quot;2&quot;>III</td>
            <td valign=&quot;top&quot;>Case series<sup>h</sup></td>
            <td valign=&quot;top&quot;>Poor reference standard</td>
            <td valign=&quot;top&quot;>Evidence provided by 1 or more well-designed clinical studies in which interobserver and intraobserver reliability is represented by a ĸ statistic of &amp;lt;0.40 or an intraclass correlation coefficient of &amp;lt;0.50</td>
        </tr>
        <tr>
            <td valign=&quot;top&quot;>Expert opinion</td>
            <td valign=&quot;top&quot;>Expert opinion</td>
            <td valign=&quot;top&quot;>&amp;nbsp;</td>
        </tr>
    </tbody>
</table>
<p class=&quot;Note&quot;><sup>a</sup>A complete assessment of quality of individual studies requires critical appraisal of all aspects of the study design.</p>
<p class=&quot;Note&quot;><sup>b</sup>A combination of results from 2 or more prior studies.</p>
<p class=&quot;Note&quot;><sup>c</sup>Studies provided consistent results.</p>
<p class=&quot;Note&quot;><sup>d</sup>Study was started before the first patient enrolled.</p>
<p class=&quot;Note&quot;><sup>e</sup>Patients treated 1 way (e.g., halo vest orthosis) compared with a group of patients treated in another way (e.g., internal fixation) at the same institution.</p>
<p class=&quot;Note&quot;><sup>f</sup>The study was started after the first patient was enrolled.</p>
<p class=&quot;Note&quot;><sup>g</sup>Patients identified for the study on the basis of their outcome, called &quot;cases&quot; (e.g., failed fusion), are compared with those who did not have outcome, called &quot;controls&quot; (e.g., successful fusion).</p>
<p class=&quot;Note&quot;><sup>h</sup>Patients treated 1 way with no comparison group of patients treated in another way.</p></div>"/>
    </field>
    <field fieldid="116" ordby="530" id="411" name="Methods Used to Analyze the Evidence" type="picklist-many">
      <fieldvalue value="Systematic Review with Evidence Tables"/>
    </field>
    <field fieldid="150" ordby="535" id="412" name="Description of the Methods Used to Analyze the Evidence" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Selected articles were carefully reviewed by the authors. An evidentiary table was created (refer to the table in the original guideline document) that reflected the strengths and weaknesses of each article.</p>
<p>On occasion, the assessed quality of the study design was so contentious and the conclusions so uncertain that the guideline authors assigned a lower medical evidence classification than might have been expected without such a detailed review. In every way, adherence to the Institute of Medicine's criteria for searching, assembling, evaluating, and weighing the available medical evidence and linking it to the strength of the recommendations presented in this document was carried out.</p>
<p>Articles that did not achieve immediate consensus among the author group were discussed extensively until a consensus was reached. Very few contributions required extensive discussion. Most articles were easily designated as containing Class I, II, or III medical evidence using the criteria set forth by the author group at the initiation of the literature evaluation process (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field).</p></div>"/>
    </field>
    <field fieldid="112" ordby="540" id="413" name="Methods Used to Formulate the Recommendations" type="picklist-choice">
      <fieldvalue value="Expert Consensus"/>
    </field>
    <field fieldid="145" ordby="545" id="414" name="Description of Methods Used to Formulate the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The current author group was selected for its expertise in spinal surgery (both neurosurgical and orthopedic), neurotrauma, clinical epidemiology, and, in several cases, prior experience with guideline development. The topics chosen for inclusion in this iteration of these guidelines are contemporary and pertinent to the assessment, evaluation, care, and treatment of patients with acute cervical spine and/or spinal cord injuries.</p></div>"/>
    </field>
    <field fieldid="146" ordby="550" id="415" name="Rating Scheme for the Strength of the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><strong>Levels of Recommendation</strong></p>
<table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Levels of Recommendation&quot;>
    <tbody>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>Level I</td>
            <td valign=&quot;top&quot;>Generally accepted principles for patient management, which reflect a high degree of clinical certainty (usually this requires Class I evidence which directly addresses the clinical questions or overwhelming Class II evidence when circumstances preclude randomized clinical trials)</td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>Level II</td>
            <td valign=&quot;top&quot;>Recommendations for patient management which reflect moderate clinical certainty (usually this requires Class II evidence or a strong consensus of Class III evidence)</td>
        </tr>
        <tr>
            <td class=&quot;Center&quot; valign=&quot;top&quot;>Level III</td>
            <td valign=&quot;top&quot;>Other strategies for patient management for which the clinical utility is uncertain (inconclusive or conflicting evidence or opinion)</td>
        </tr>
    </tbody>
</table></div>"/>
    </field>
    <field fieldid="148" ordby="565" id="417" name="Cost Analysis" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div>"/>
    </field>
    <field fieldid="104" ordby="570" id="418" name="Method of Guideline Validation" type="picklist-choice">
      <fieldvalue value="Not stated"/>
    </field>
    <field fieldid="130" ordby="575" id="419" name="Description of Method of Guideline Validation" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Not applicable</p></div>"/>
    </field>
  </section>
  <section secid="424" ordby="600" name="Evidence Supporting the Recommendations">
    <field fieldid="139" ordby="610" id="426" name="Type of Evidence Supporting the Recommendations" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The type of supporting evidence is identified and graded for each recommendation (see the &quot;Major Recommendations&quot; field).</p></div>"/>
    </field>
  </section>
  <section secid="427" ordby="700" name="Benefits/Harms of Implementing the Guideline Recommendations">
    <field fieldid="152" ordby="705" id="428" name="Potential Benefits" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The potential benefits of enteral feeding over parenteral delivery include maintenance of gut integrity and function, reduced expense, lower risk of infection and avoidance of intravenous catheter-related complications. Nasoduodenal or nasojejunal feeding tubes usually allow full caloric, high-nitrogen, high-volume feeding within days of injury.</p></div>"/>
    </field>
    <field fieldid="153" ordby="710" id="429" name="Potential Harms" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>In a published retrospective study of a group of 33 patients who received enteral feeding at a median of 2 days (range 0.5-4.8 days) following admission, the most common reason for interruption of enteral feeds was high gastric aspirates, which occurred in 67% of patients. Two patients developed ileus, requiring conversion from nasogastric to nasojejunal feeding tubes.</p></div>"/>
    </field>
  </section>
  <section secid="432" ordby="900" name="Qualifying Statements">
    <field fieldid="137" ordby="905" id="433" name="Qualifying Statements" type="text">
      <fieldvalue value="<ul style=&quot;list-style-type: disc;&quot;>
    <li>Medical evidence-based guidelines are not meant to be restrictive or to limit a clinician's practice. They chronicle multiple successful treatment options (for example) and stratify the more successful and the less successful strategies based on scientific merit. They are not absolute, &quot;must be followed&quot; rules. This process may identify the most valid and reliable imaging strategy for a given injury, for example, but because of regional or institutional resources, or patient co-morbidity, that particular imaging strategy may not be possible for a patient with that injury. Alternative acceptable imaging options may be more practical or applicable in this hypothetical circumstance. </li>
    <li>Guidelines documents are not tools to be used by external agencies to measure or control the care provided by clinicians. They are not medical-legal instruments or a &quot;set of certainties&quot; that must be followed in the assessment or treatment of the individual pathology in the individual patients we treat. While a powerful and comprehensive resource tool, guidelines and the recommendations contained therein do not necessarily represent &quot;the answer&quot; for the medical and surgical dilemmas faced with many patients. </li>
</ul>"/>
    </field>
  </section>
  <section secid="434" ordby="1000" name="Implementation of the Guideline">
    <field fieldid="131" ordby="1010" id="436" name="Description of Implementation Strategy" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>An implementation strategy was not provided.</p></div>"/>
    </field>
    <field fieldid="117" ordby="1015" id="437" name="Implementation Tools" type="picklist-many">
      <fieldvalue value="Mobile Device Resources"/>
    </field>
  </section>
  <section secid="439" ordby="1100" name="Institute of Medicine (IOM) National Healthcare Quality Report Categories">
    <field fieldid="50" ordby="1105" id="440" name="IOM Care Need" type="picklist-many">
      <fieldvalue value="Getting Better"/>
    </field>
    <field fieldid="51" ordby="1110" id="441" name="IOM Domain" type="picklist-many">
      <fieldvalue value="Effectiveness"/>
    </field>
  </section>
  <section secid="442" ordby="1200" name="Identifying Information and Availability">
    <field fieldid="97" ordby="1201" id="392" name="Bibliographic Source(s)" type="citation">
      <fieldvalue value="<table><tr><td>Dhall SS, Hadley MN, Aarabi B, Gelb DE, Hurlbert RJ, Rozzelle CJ, Ryken TC, Theodore N, Walters BC. Nutritional support after spinal cord injury. In: Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery. 2013 Mar;72(Suppl 2):255-9. [27 references] <a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=23417196&quot; target=&quot;_blank&quot;>PubMed</a></td></tr></table>"/>
    </field>
    <field fieldid="124" ordby="1205" id="443" name="Adaptation" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Not applicable: The guideline was not adapted from another source.</p></div>"/>
    </field>
    <field fieldid="128" ordby="1215" id="445" name="Date Released" type="text">
      <fieldvalue value="2013 Mar"/>
    </field>
    <field fieldid="158" ordby="1225" id="447" name="Guideline Developer(s)" type="orglist-p">
      <fieldvalue value="American Association of Neurological Surgeons - Medical Specialty Society"/>
      <fieldvalue value="Congress of Neurological Surgeons - Professional Association"/>
    </field>
    <field fieldid="125" ordby="1235" id="449" name="Source(s) of Funding" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Congress of Neurological Surgeons</p></div>"/>
    </field>
    <field fieldid="126" ordby="1240" id="450" name="Guideline Committee" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Guidelines Author Group of the Joint Section of Disorders of the Spine and Peripheral Nerves of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons</p></div>"/>
    </field>
    <field fieldid="127" ordby="1245" id="451" name="Composition of Group That Authored the Guideline" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p><em>Authors</em>: Sanjay S. Dhall, MD, Department of Neurosurgery, Emory University, Atlanta, Georgia; Mark N. Hadley, MD (<em>Lead Author</em>), Division of Neurological Surgery, University of Alabama at Birmingham, Birmingham, Alabama; Bizhan Aarabi, MD, FRCSC, Department of Neurosurgery, University of Maryland, Baltimore, Maryland; Daniel E. Gelb, MD, Department of Orthopaedics, University of Maryland, Baltimore, Maryland; R. John Hurlbert, MD, PhD, FRCSC, Department of Clinical Neurosciences, University of Calgary Spine Program, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; Curtis J. Rozzelle, MD, Division of Neurological Surgery, Children's Hospital of Alabama, University of Alabama at Birmingham, Birmingham, Alabama; Timothy C. Ryken, MD, MS, Iowa Spine &amp;amp; Brain Institute, University of Iowa, Waterloo/Iowa City, Iowa; Nicholas Theodore, MD, Division of Neurological Surgery, Barrow Neurological Institute, Phoenix, Arizona; Beverly C. Walters, MD, MSc, FRCSC (<em>Lead Author</em>), Division of Neurological Surgery, University of Alabama at Birmingham, Birmingham, Alabama, Department of Neurosciences, Inova Health System, Falls Church, Virginia</p></div>"/>
    </field>
    <field fieldid="147" ordby="1250" id="452" name="Financial Disclosures/Conflicts of Interest" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this guideline.</p></div>"/>
    </field>
    <field fieldid="120" ordby="1256" id="393" name="Guideline Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This is the current release of the guideline.</p></div>"/>
    </field>
    <field fieldid="118" ordby="1260" id="454" name="Guideline Availability" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>Available from the <a href=&quot;http://journals.lww.com/neurosurgery/Fulltext/2013/03002/Nutritional_Support_After_Spinal_Cord_Injury.26.aspx&quot; title=&quot;Neurosurgery Web site&quot;>Neurosurgery Web site</a>.</p></div>"/>
    </field>
    <field fieldid="119" ordby="1265" id="455" name="Availability of Companion Documents" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>The following are available:</p>
<ul style=&quot;list-style-type: disc;&quot;>
    <li>Foreword. Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery 2013;72(3):1. Available from the <a href=&quot;http://journals.lww.com/neurosurgery/Fulltext/2013/03002/Foreword.1.aspx&quot; title=&quot;Neurosurgery Web site&quot;>Neurosurgery Web site</a>. </li>
    <li>Commentary. Guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery 2013;72(3):2-3. Available from the <a href=&quot;http://journals.lww.com/neurosurgery/Fulltext/2013/03002/Commentary.2.aspx&quot; title=&quot;Neurosurgery Web site&quot;>Neurosurgery Web site</a>. </li>
    <li>Introduction to the guidelines for the management of acute cervical spine and spinal cord injuries. Neurosurgery 2013;72(3):5-16. Available from the <a href=&quot;http://journals.lww.com/neurosurgery/Fulltext/2013/03002/Introduction_to_the_Guidelines_for_the_Management.4.aspx&quot; tilte=&quot;Neurosurgery Web site&quot;>Neurosurgery Web site</a>. </li>
    <li>Methodology of the guidelines for management of acute cervical spine and spinal cord injuries. Neurosurgery 2013;72(3):17-21. Available from the <a href=&quot;http://journals.lww.com/neurosurgery/Fulltext/2013/03002/Methodology_of_the_Guidelines_for_the_Management.5.aspx&quot; title=&quot;Neurosurgery Web site&quot;>Neurosurgery Web site</a>. </li>
</ul></div>"/>
    </field>
    <field fieldid="143" ordby="1275" id="457" name="Patient Resources" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>None available</p></div>"/>
    </field>
    <field fieldid="142" ordby="1280" id="458" name="NGC Status" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This NGC summary was completed by ECRI Institute on July 9, 2013. The information was verified by the guideline developer on October 3, 2013.</p></div>"/>
    </field>
    <field fieldid="141" ordby="1290" id="460" name="Copyright Statement" type="text">
      <fieldvalue value="<div class=&quot;content_para&quot;><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.</p></div>"/>
    </field>
  </section>
  <section secid="99999" ordby="99999" name="Disclaimer">
    <field fieldid="99999" ordby="99999" id="99999" name="NGC Disclaimer" type="text">
      <fieldvalue value="<p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;>NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p>"/>
    </field>
  </section>
</version><!--
     FILE ARCHIVED ON 01:07:27 Jul 16, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 01:07:28 Jul 16, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 124.443 (3)
  esindex: 0.01
  captures_list: 143.704
  CDXLines.iter: 13.787 (3)
  PetaboxLoader3.datanode: 124.274 (4)
  exclusion.robots: 0.451
  exclusion.robots.policy: 0.428
  RedisCDXSource: 0.721
  PetaboxLoader3.resolve: 203.233
  load_resource: 245.628
-->